Calls
2
u/Beautiful-Cod-3414
Reddit r/pennystocks
Win Rate
0.0%
return
-40.9%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 13
$5.70
-34.2%
The author is bullish on Inventiva, which presented at JPM Healthcare 2026 and is in the final stages of Phase 3 trials for its MASH drug lanifibranor. The author notes that unlike Madrigal's drug, lanifibranor is taken orally and its results are impressive. The author believes it could become the second approved drug in the huge MASH market and that the company is completely under the radar, similar to ABIVAX previously.
Pharma & Biotech
Long
Jan 12
$21.70
-47.5%
The author thinks GomSpace has a bright future because in recent years it has specialized in civilian and military nanosatellites, particularly for surveillance. As a Danish company, it is described as being at the heart of current and future tensions concerning Arctic shipping routes, with the situation in Greenland very topical and potentially putting it in the spotlight. The author notes it rose 9% at today's close, but provides no concrete catalyst, financial mechanism, or timeframe beyond the geopolitical theme.
Other
Showing 2 of 2 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Beautiful-Cod-3414 has 2 trade ideas tracked on Buzzberg across 2 tickers since January 2026. Most covered: IVA, GOMX.ST.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
